FDA
- Status: approved
remimazolam sedation reversal with flumazenil (remimazolam sedation reversal with flumazenil) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Medical University of Gdansk is the originator. The local marketing authorisation holder may differ — check the official source linked above.